The Validity of the EuroQol Health and Wellbeing Short Version (EQ-HWB-S) Instrument in Parents of Children With and Without Health Conditions.

The Validity of the EuroQol Health and Wellbeing Short Version (EQ-HWB-S) Instrument in Parents of Children With and Without Health Conditions.

Publication date: Jan 18, 2024

The EuroQol Health and Wellbeing Short Version (EQ-HWB-S) instrument has been developed to measure the health and wellbeing of care-recipients and their caregivers for use in economic evaluation. The EQ-HWB-S has nine items, and pilot UK preference weights have now been developed. We aimed to investigate the validity of the instrument in parents of children with and without health conditions. EQ-HWB-S data were sourced from an Australian paediatric multi-instrument comparison study. We analysed the baseline characteristics and response distribution of the EQ-HWB-S items. Assessment of known-group validity was conducted for EQ-HWB-S items, level sum-scores and preference-weighted scores, including partial effects. Known-group analyses included three child health variables and where caregivers reported coronavirus disease 2019 (COVID-19) had impacted their wellbeing. We included analyses across gender, controlled for child and parent demographic variables, and compared scores across child health conditions. Item responses were distributed as expected, with higher skew for mobility and activities. Parents experienced high levels of exhaustion. We detected significant differences between groups for level sum-scores and preference-weighted scores, as hypothesised; all tests were significant (p 

Open Access PDF

Concepts Keywords
Australian Caregivers
Caregivers Conditions
Coronavirus Developed
Pharmacoeconomics Eq
Pilot Euroqol


Type Source Name
disease MESH coronavirus disease 2019
disease VO population
disease MESH dementia
drug DRUGBANK Trestolone
disease VO USA
disease MESH mental illnesses
disease MESH caregiver burden
disease MESH autism spectrum disorder
disease MESH cerebral palsy
disease MESH loneliness
drug DRUGBANK Ademetionine
disease MESH chronic condition
drug DRUGBANK Methyl isocyanate
disease MESH ADHD
disease MESH asthma
pathway KEGG Asthma
disease MESH epilepsy
drug DRUGBANK Ranitidine
disease VO protocol
pathway REACTOME Vitamins
disease IDO quality
disease MESH eating disorders
disease VO time
drug DRUGBANK Coenzyme M
disease VO frequency
drug DRUGBANK Hyaluronic acid
disease MESH education level
disease MESH sleep disorder
disease MESH autism
drug DRUGBANK Esomeprazole
drug DRUGBANK Aspartame
disease MESH burnout
drug DRUGBANK Trihexyphenidyl
drug DRUGBANK Profenamine
disease VO report

Original Article

(Visited 1 times, 1 visits today)